SG11202003130TA - Prognostic and treatment response predictive method - Google Patents
Prognostic and treatment response predictive methodInfo
- Publication number
- SG11202003130TA SG11202003130TA SG11202003130TA SG11202003130TA SG11202003130TA SG 11202003130T A SG11202003130T A SG 11202003130TA SG 11202003130T A SG11202003130T A SG 11202003130TA SG 11202003130T A SG11202003130T A SG 11202003130TA SG 11202003130T A SG11202003130T A SG 11202003130TA
- Authority
- SG
- Singapore
- Prior art keywords
- prognostic
- treatment response
- predictive method
- response predictive
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1716712.3A GB201716712D0 (en) | 2017-10-12 | 2017-10-12 | Prognostic and treatment response predictive method |
| PCT/SG2018/050514 WO2019074445A1 (en) | 2017-10-12 | 2018-10-12 | Prognostic and treatment response predictive method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202003130TA true SG11202003130TA (en) | 2020-05-28 |
Family
ID=60419099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202003130TA SG11202003130TA (en) | 2017-10-12 | 2018-10-12 | Prognostic and treatment response predictive method |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11788148B2 (en) |
| EP (1) | EP3695014B1 (en) |
| AU (1) | AU2018349796B2 (en) |
| CA (1) | CA3078109A1 (en) |
| GB (1) | GB201716712D0 (en) |
| SG (1) | SG11202003130TA (en) |
| WO (1) | WO2019074445A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019237015A1 (en) * | 2018-06-08 | 2019-12-12 | The Trustees Of Columbia University In The City Of New York | Methods and systems for predicting success rates of clinical trials |
| CN112102879B (en) * | 2020-07-31 | 2023-05-09 | 蒋涛 | System and method for predicting curative effect of advanced lung cancer chemotherapy |
| CN112908477A (en) * | 2021-01-28 | 2021-06-04 | 黑龙江省医院 | Prognosis risk assessment system for gastric cancer patient |
| CN114113012B (en) * | 2021-11-08 | 2023-06-13 | 北京市肿瘤防治研究所 | Analysis method and application of HER2 positive gastric cancer immune microenvironment characteristics |
| CN114807374A (en) * | 2022-06-01 | 2022-07-29 | 北京大学第三医院（北京大学第三临床医学院） | Ovarian cancer prognosis risk model based on polyunsaturated fatty acid related genes and preparation method and application thereof |
| CN115409771B (en) * | 2022-06-10 | 2023-07-25 | 浙江大学 | Ovarian cancer survival prediction system constructed based on sample change stability characteristics |
| CN117153241A (en) * | 2023-09-21 | 2023-12-01 | 浙江省肿瘤医院 | Prediction model of triple negative breast cancer prognosis effect and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004248120B2 (en) | 2003-05-28 | 2009-04-23 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| US20130064901A1 (en) | 2011-04-18 | 2013-03-14 | Agency For Science, Technology And Research | Gene expression profiling for classifying and treating gastric cancer |
| JPWO2012157647A1 (en) * | 2011-05-16 | 2014-07-31 | 大鵬薬品工業株式会社 | Chemotherapy selection method comprising tegafur, gimeracil, oteracil potassium combination agent and EGFR inhibitor for gastric cancer patients |
| GB201316027D0 (en) | 2013-09-09 | 2013-10-23 | Almac Diagnostics Ltd | Molecular diagnostic test for oesophageal cancer |
-
2017
- 2017-10-12 GB GBGB1716712.3A patent/GB201716712D0/en not_active Ceased
-
2018
- 2018-10-12 US US16/755,085 patent/US11788148B2/en active Active
- 2018-10-12 SG SG11202003130TA patent/SG11202003130TA/en unknown
- 2018-10-12 EP EP18792565.6A patent/EP3695014B1/en active Active
- 2018-10-12 AU AU2018349796A patent/AU2018349796B2/en active Active
- 2018-10-12 WO PCT/SG2018/050514 patent/WO2019074445A1/en unknown
- 2018-10-12 CA CA3078109A patent/CA3078109A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018349796A1 (en) | 2020-04-30 |
| WO2019074445A1 (en) | 2019-04-18 |
| US11788148B2 (en) | 2023-10-17 |
| US20200239968A1 (en) | 2020-07-30 |
| EP3695014A1 (en) | 2020-08-19 |
| EP3695014B1 (en) | 2021-04-14 |
| CA3078109A1 (en) | 2019-04-18 |
| GB201716712D0 (en) | 2017-11-29 |
| AU2018349796B2 (en) | 2023-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3562213C0 (en) | Access control method and device | |
| SG11202001176QA (en) | System and method for predictive cleaning | |
| SG11202003130TA (en) | Prognostic and treatment response predictive method | |
| GB201810190D0 (en) | Prognostic and treatment response predictive method | |
| SG11201505982VA (en) | Control method of information device, and program | |
| TWI561718B (en) | Door-lock system and door-lock control method | |
| SG11201706914TA (en) | Memory device controlling method and memory device | |
| GB201611698D0 (en) | Blockchain-implemented control method and system | |
| GB201718338D0 (en) | Controller and method | |
| IL268985A (en) | Method for assessing and treating cellulite | |
| GB201718916D0 (en) | Sensor and method | |
| GB201805021D0 (en) | Method and use | |
| GB201805042D0 (en) | Method and use | |
| GB201805103D0 (en) | Method and use | |
| GB201805024D0 (en) | Method and use | |
| GB201601567D0 (en) | Control system and method | |
| GB201711782D0 (en) | Diagnostic and Prognostic methods | |
| GB201601942D0 (en) | Cache and method | |
| GB201703406D0 (en) | Diagnostic and prognostic methods | |
| GB2559989B (en) | Well access apparatus and method | |
| HK1255858A1 (en) | Information processing device, elevator device, and program update method | |
| SG11201912027UA (en) | Access control method and related product | |
| IL261535B (en) | Access control system and method thereof | |
| GB2568504B (en) | Controller and method | |
| GB201621899D0 (en) | Predictive analytics system and method |